At the time of writing this editorial, I have been in health care for exactly 45 years. These years have taken me through many challenging settings, including intensive cares, emergency departments, operating rooms, acute and chronic care wards, therapy/outpatient clinics and land/air transport teams, etc., etc. Over that time, I learned so much from so many. But, there has always been one aspect of clinical practice in all these settings that has always left me wondering why. That practice is the ambivalence around removing air bubbles from an intravenous (IV) line before it enters the patient's venous circulation.
There are many ways air can enter the venous circulation (renal dialysis, venous catheter placement, endoscopic procedures, diagnostic procedures, neurosurgery, etc.), but the focus of this editorial is on the venous air from intravenous line therapy. When it comes to air bubbles in IV lines, the common thought is "a little air will never hurt anyone' . In fact, this singular statement is repeated daily and is continually regurgitated to patients, students and experienced clinicians alike, at all levels of health care. Unfortunately, over many decades, it has now become a self-perpetuating myth. Most of the literature on this topic is done in animals and mainly has a focus on the acute findings related to large volumes of air through IV lines and its association to blood pressure and/or cardiac arrest. But, to this day, there is an unsupported broad-based opinion in medicine that suggests small or moderate volumes of air in an intravenous line is essentially harmless and, therefore, is of little concern.
Evidence relating morbidity and mortality to venous air emboli (VAE) can be traced back to the 19th century (1839 and 1885) when two significant publications on problems associated with VAE were first published. 1, 2 More recent investigations in animals found that slow infusions of air over 3 minutes or rapid infusions of an air bolus can create three different physiological responses in animals: 1) infusions of 0.4-0.6 ml/Kg/min (24-36 ml in a 60 Kg patient) can cause a moderate decrease in blood pressure, which is compensated by an increased cardiac output; 2) infusions between 1.2-1.8 ml/Kg/min (72-108 ml in a 60 Kg patient) can cause an uncompensated decrease in blood pressure and conduction changes in the heart; and 3) infusions >1.8 ml/Kg/min (>108 ml in a 60 Kg patient) cause abrupt decreases in blood pressure, shock and death. 3 It now appears that we have become so comfortable with this issue that small volumes of air entering a vein through an IV line is often essentially ignored and believed to be harmless when the volumes are less than 50 ml. Unfortunately, there is no evidence to support this statement. No harm is ever intended, assumed or even imagined, because it is often just a part of the routine practice of maintaining an intravenous infusion and the culture of misinformation around the hazards of air bubbles entering the venous circulation. Of course, there will always be times when some levels of clinical care dictate that air bubbles in the IV line are the least of an individual's problems. But, for the vast majority of patients with intravenous lines, is it really safe or even good practice to dismiss all concerns about air bubbles in the IV line, regardless of the amount?
There are several reasons why air (in any amount) should not be allowed to pass through an IV line into a patient, the most obvious of which is -air bubbles in an IV line should not even be there if the line is flushed and maintained properly. The reality is, even small amounts of air have the potential to create adverse consequences and can be harmful to a patient, especially if these venous air emboli transit from the right side of the heart to the left side of the heart, a situation that is referred to as Paradoxical Air Emboli (PAE). Unfortunately, paradoxical air emboli have the potential to negatively impact the cerebral circulation.
In the microcirculation, systemic capillaries range between 4-9 microns in diameter 4 and pulmonary capillaries are reported to be approximately 5-6 microns in diameter, 5 which is why much of the filtration media used in cardiovascular surgery revolves around preventing gaseous microbubbles >20 microns in diameter from entering the patient's arterial circulation. Even though the definition of a microbubble is <1000 microns (1 mm) in diameter, 6 air bubbles in intravenous lines are very often much larger than 1 mm. An IV-line gas bubble as small as 1 mm is still >1000 microns in diameter and is, therefore, considered to be a macrobubble and can dramatically impact the microcirculation.
Air in intravenous lines: a need to review old opinions
706834P RF0010.1177/0267659117706834PerfusionEditorial editorial2017
Editorial
When an air bolus enters the cardiac chambers, it does not stay in the same state as it passes through the vascular system. The bolus actually gets broken into thousands of smaller microbubbles by the constant, forceful beating of the heart. The fate of gas bubbles in blood is a much debated and complicated physiological mechanism which depends on the size, the composition, the rate and the location of air bubbles. But, regardless of the size of the air bubbles, they all have the ability to coalesce on contact to form larger bubbles and they all are considered foreign to our circulation and are treated like any other foreign substance that enters our blood's natural defense mechanisms. The bubbles are immediately coated by platelets, white blood cells and other denatured proteins as they enter the bloodstream and travel towards and through the right side of the heart. For this reason, the walls of the gas bubbles become thicker, take longer to adsorb and have the ability to adhere to exposed endothelial cell surfaces. During their course through the venous circulation, they can act as a solid embolus with a compressible gas core and can, therefore, damage/ degrade the intraluminal endothelial glycocalyx lining (EGL) and even lodge in the pulmonary microcirculation, thereby, acting in both a destructive and obstructive manner. [7] [8] [9] Subsequently, the damaged/degraded EGL would result in localized endothelial edema, inflammation, localized platelet/white cell activation and contribute to post-obstruction ischemia. Over time, these bubbles gradually dissolve in the blood, but not before damaging the EGL, initiating intravascular to extravascular fluid extravasation and activating the compliment/ coagulation cascade. 8, [10] [11] [12] Air entering the venous circulation through an intravenous line has the potential to migrate into the superior vena cava and, subsequently, into the patient's cerebral circulation, because the internal and external jugular veins come directly off the subclavian and bracheocephalic veins, which subsequently drain the right and left arms' circulation. This is especially relevant if the patient is in a sitting position. 13, 14 The term used for the latter is retrograde cerebral air embolism and is influenced by such factors as cardiac output, rate of infusion and bubble size. [13] [14] [15] On the other hand, air bubbles found in the cardiac chambers of the heart when a patient is in the supine position have been known to persist for >45 minutes before the bubbles are either dislodged or adsorbed. 16 Another consideration with gas bubbles in the IV line is the potential for them to migrate directly into the left side of the heart as a PAE when an unknown patent foramen ovale (PFO) or atrial septal defect (ASD) is present in the patient. Most PFOs are detected early in life, but it is known to still be present in about 10% to 35% of adults (some report 25-45% found during autopsy) 17 and is considered to be an important risk factor for strokes, cerebrovascular accidents and transient ischemic attacks. 18 Some people know they have a PFO, but, unfortunately, many adults do not, 19 which increases the risk of PAE when air bubbles are allowed to enter the venous circulation through an IV line. This potential for PAE is a significant concern in pediatric patients with complicated anatomy or in the presence of a known PFO or ASD. 20, 21 What is almost paradoxical is the fact that, in order to determine if an adult has a PFO, cardiology will perform a test called the 'bubble study' . Unfortunately, this diagnostic technique is often quoted as a justification around the insignificance of microbubbles in the venous circulation. The bubble study is a risky test where a fixed amount of saline solution (usually 9.0 ml) is mixed with a fixed amount of air (usually 1.0 ml) and agitated in the syringe to create a large amount of small microbubbles. 22 This microembolic solution is then injected into a vein while transesophageal echocardiography is used to see if any of the injected microbubbles are transmitted to the left side of the heart. Theoretically, if a PFO does exist, air bubbles will be detected on the left side of the heart, but in the absence of a PFO, all of the microair will transit into the pulmonary circulation. The incidence of stroke associated with the bubble study is essentially unknown and it is stated that there is no official registry for cardiologists to report the harmful effects of such PAE events or any adverse events associated with these studies. However, investigators have found that ischemic cerebrovascular complications, such as transient ischemic attacks (TIA) and ischemic strokes, have occurred in patients with detected PAE during these 'bubble studies' . 23 On a global scale, strokes are considered to be the second leading cause of death. 24 Ischemic strokes that occur with an unknown etiology are called cryptogenic strokes. In a study of 287 young adults with ischemic strokes, 43% of the strokes were found to be cryptogenic in nature. 25 In fact, 87% of all strokes reported in the United States (678,000) were found to be ischemic strokes, 26 and 30% of all ischemic strokes are classified as embolic in nature. 27 Searching for the causes of cryptogenic strokes often involves looking for the possibility of PAE in the presence of right to left shunts (especially in the young), but, of course, they are not the only potential source of cryptogenic strokes. 23, 28 PAE can also occur through venous-arterial (v-a) shunts that exist in the lung, called Intrapulmonary Arterial-Venous Anastomoses (IPAVA), which are simply v-a shunts (≈ 25 microns in diameter) that do not come in contact with the air sacs in our lungs and are, thereby, a source for the increased probability that both venous blood and air bubbles will pass directly into the left side of the heart. 29 Several studies have found that blood flow through these IPAVA shunts were found in 28% of adults at rest and >95% of adults during exercise.
The presence of IPAVA shunts is also suspected to be a potential source for cryptogenic strokes. 30, 31 There are several other less common sources of right to left blood shunting where air bubbles in the IV line could compromise patient safety and increase patient morbidity. Some of these are: ventricular septal defects, atrioventricular defects, tetralogy of Fallot, persistent truncus arteriosus and transposition of the great arteries.
When we consider the intraluminal glycocalyx damage that is created by air bubbles, the potential for pulmonary capillary occlusion and the significant odds of paradoxical air embolism and stroke through such sources as retrograde cerebral air embolism, PFO, IPAVA and other congenital abnormalities, we have to ask the questions: Why do clinicians continue to allow air bubbles to enter the venous circulation through IV lines and why do we continue to minimize the hazards associated with air in the venous circulation?
There is a significant and urgent need to re-educate health care practitioners on the hazards of air in intravenous lines and, eventually, eliminate the myth that a little air will not hurt anyone. Of course, there will always be times when intravenous air is unavoidable, but, in the vast majority of cases, it is avoidable with a little understanding, time and attention. Certainly, there seems to be a renewed interest in the topic of IV air bubbles, which is evident in a short LinkedIn blog I wrote about this very topic. Since the start of 2016, this blog has now been viewed over 24,000 times and is still growing at a rate of 400-500 views per week.
Perhaps an easier, but more expensive approach to address this issue of IV air is through the use of air removal devices and intravenous-line air filters. The smallest of these filters used in IV lines are 0.2 microns in size and are very effective in not only removing IV air, but precipitates, bacteria, fragments of glass, plastic and rubber. Since most bacteria (including gram negative bacteria) range in size between 1.0 and 5.0 microns, these IV filters can be very useful in reducing bacterial contaminants from entering the bloodstream through intravenous fluids 32 if used according to manufactures specifications. 33 In many pediatric centers, IV filters are often used in neonatal and pediatric cases where they suspect the presence of a PFO, but they are generally not used in the adult population when IV fluids are administered. Irrespective of the costs associated with IV-line air filters, perhaps they should be a routine part of intravenous fluid therapy because they have the ability to reduce morbidity and mortality associated with IV infusions. We do not know the incidence of stroke caused by PAE and intravenous air, but we do know the potential exists for the presence of cryptogenic strokes if intravenous air passes from the right side of the heart to the left side of the heart through several physiological or anatomical mechanisms present in the general population.
The culture of "a little air won't hurt you" is as outdated as the Model T Ford and it is time to stop perpetuating this misguided belief on future generations of health care workers.
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